David F Moreno

14PUBLICATIONS
70CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 13, 2026
Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|Dec 06, 2024
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells.

Anthony M Battram, Joan Mañé-Pujol, David F Moreno

|Nov 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés

|Nov 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry.

David F Moreno, Cristina Jiménez, Fernando Escalante

|Jul 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma.

Ester Lozano, Mari-Pau Mena, Glòria Garrabou

Pageof 3

Frequent Collaborators

12 joint publications

Carlos Fernández de Larrea

8 joint publications

Luis-Gerardo Rodríguez-Lobato

8 joint publications

Aina Oliver-Caldés

7 joint publications

Laura Rosiñol